Pharmacological interventions for painful sickle cell vaso-occlusive crises in adults

Authors

Tess E. Cooper, University of Oxford
Ian R. Hambleton, The University of the West Indies
Samir K. Ballas, Thomas Jefferson UniversityFollow
Philip J. Wiffen, University of Oxford

Document Type

Article

Publication Date

5-9-2016

Comments

This Cochrane Review is published in the Cochrane Database of Systematic Reviews 2016, Issue 5. Cochrane Reviews are regularly updated as new evidence emerges and in response to feedback, and the Cochrane Database of Systematic Reviews should be consulted for the most recent version of the Review.

Cooper, T. E., Hambleton, I. R., Ballas, S. K., & Wiffen, P. J.. Pharmacological interventions for painful sickle cell vaso-occlusive crises in adults. Cochrane Database of Systematic Reviews 2016, Issue 5. Art. No.: CD012187. DOI: 10.1002/14651858.CD012187

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the analgesic efficacy, and adverse events, of pharmacological interventions used to treat acute painful sickle cell vaso-occlusive crises in adults, aged 18 and over, in any setting.

Recommended Citation

Cooper, Tess E.; Hambleton, Ian R.; Ballas, Samir K.; and Wiffen, Philip J., "Pharmacological interventions for painful sickle cell vaso-occlusive crises in adults" (2016). Cardeza Foundation for Hematologic Research. Paper 35.
https://jdc.jefferson.edu/cardeza_foundation/35